161 related articles for article (PubMed ID: 35655921)
1. Identification of Significant Secreted or Membrane-Located Proteins in Laryngeal Squamous Cell Carcinoma.
Yan L; Hu C; Ji Y; Zou L; Zhao Y; Zhu Y; Wang X
J Immunol Res; 2022; 2022():9089397. PubMed ID: 35655921
[TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of Immune Infiltration Phenotypes in Laryngeal Squamous Cell Carcinoma by Integrative Multi-Omics Analysis.
Yan L; Song X; Yang G; Zou L; Zhu Y; Wang X
Front Immunol; 2022; 13():843467. PubMed ID: 35281069
[TBL] [Abstract][Full Text] [Related]
3. The matrix metalloproteinase gene family: a significant prognostic gene lineage correlated with immune infiltrates in laryngeal squamous cell carcinoma.
Yang C; Cao H; Yang JW; Liu T; Wang JT; Wang BS
Neoplasma; 2021 Nov; 68(6):1212-1224. PubMed ID: 34585589
[TBL] [Abstract][Full Text] [Related]
4. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
Qian L; Ni T; Fei B; Sun H; Ni H
BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824
[TBL] [Abstract][Full Text] [Related]
5. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of transcription factor WD repeat and HMG-box DNA binding protein 1 in laryngeal squamous cell carcinoma and its potential molecular mechanism.
Wu JY; Lan XL; Yan DM; Fang YY; Peng YX; Liang FF; Jiang L; Huang SN; Mo M; Lin CX; Niu YT; Wu XW; Wei ZX
Pathol Res Pract; 2022 Feb; 230():153751. PubMed ID: 34999279
[TBL] [Abstract][Full Text] [Related]
8. Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinoma.
Sun M; Chen S; Fu M
Medicine (Baltimore); 2021 Jan; 100(2):e24263. PubMed ID: 33466212
[TBL] [Abstract][Full Text] [Related]
9. The clinical significance of interleukin 24 and its potential molecular mechanism in laryngeal squamous cell carcinoma.
Tang XZ; Zhou XG; Zhang XG; Li GS; Chen G; Dang YW; Huang ZG; Li MX; Liang Y; Yao YX; Chen XY; Rong MH; Huang SN
Cancer Biomark; 2020; 29(1):111-124. PubMed ID: 32623386
[TBL] [Abstract][Full Text] [Related]
10. Construction of a novel MPT-driven necrosis-related lncRNAs signature for prognosis prediction in laryngeal squamous cell carcinoma.
Liu J; Zhang M; Sun Q; Qin X; Gao T; Xu Y; Han S; Zhang Y; Guo Z
Environ Sci Pollut Res Int; 2023 Jul; 30(31):77210-77225. PubMed ID: 37249774
[TBL] [Abstract][Full Text] [Related]
11. Prognostic nomogram based on immune scores for laryngeal squamous cell cancer.
Liao L; Chen W; Lai H; Yi X; Wang D
Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):141-148. PubMed ID: 32638085
[TBL] [Abstract][Full Text] [Related]
12. Identification of MMP1 and MMP2 by RNA-seq analysis in laryngeal squamous cell carcinoma.
Fang W; Shen J
Am J Otolaryngol; 2020; 41(3):102391. PubMed ID: 31932027
[TBL] [Abstract][Full Text] [Related]
13. RUNX1-BMP2 promotes vasculogenic mimicry in laryngeal squamous cell carcinoma via activation of the PI3K-AKT signaling pathway.
Zhu Q; Zhang X; Lu F; Miao S; Zhang C; Liu Z; Gao Z; Qi M; An X; Geng P; Wang S; Ren H; Han F; Zhang R; Zha D
Cell Commun Signal; 2024 Apr; 22(1):227. PubMed ID: 38610001
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity analysis of the immune microenvironment in laryngeal carcinoma revealed potential prognostic biomarkers.
Qian Z; Shang D; Fan L; Zhang J; Ji L; Chen K; Zhao R
Hum Mol Genet; 2022 May; 31(9):1487-1499. PubMed ID: 34791236
[TBL] [Abstract][Full Text] [Related]
15. ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma.
Zhou C; Shen Y; Wei Z; Shen Z; Tang M; Shen Y; Deng H
J Clin Lab Anal; 2022 Feb; 36(2):e24228. PubMed ID: 34994984
[TBL] [Abstract][Full Text] [Related]
16. A novel signature derived from metabolism-related genes GPT and SMS to predict prognosis of laryngeal squamous cell carcinoma.
Shen Y; Huang Q; Zhang Y; Hsueh CY; Zhou L
Cancer Cell Int; 2022 Jul; 22(1):226. PubMed ID: 35804447
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatic analysis reveals prognostic value and immunotherapy potential of Siglec-15 in laryngeal squamous cell carcinoma.
Chen X; Cai Q; Wong K; Shen X; Guan Z
Heliyon; 2024 Feb; 10(3):e25266. PubMed ID: 38352733
[TBL] [Abstract][Full Text] [Related]
18. Identification of core biomarkers associated with pathogenesis and prognostic outcomes of laryngeal squamous-cell cancer using bioinformatics analysis.
Chen W; Liao L; Lai H; Yi X; Wang D
Eur Arch Otorhinolaryngol; 2020 May; 277(5):1397-1408. PubMed ID: 32067095
[TBL] [Abstract][Full Text] [Related]
19. APE1 facilitates PD-L1-mediated progression of laryngeal and hypopharyngeal squamous cell carcinoma.
Wang J; Lun L; Jiang X; Wang Y; Li X; Du G; Wang J
Int Immunopharmacol; 2021 Aug; 97():107675. PubMed ID: 33964809
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma.
Zhou G; Zhang S; Jin M; Hu S
BMC Cancer; 2022 Jun; 22(1):667. PubMed ID: 35715770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
